Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24218528 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
Conditions: Parkinson's Disease;   Apathy;   no Dementia
Interventions: Drug: rivastigmine;   Drug: placebo

Indicates status has not been verified in more than two years